Van Eck Associates Corp GW Pharmaceuticals PLC Transaction History

Van Eck Associates Corp

$78.1 Billion
Q4 2024

Shares

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 10, 2021	SELL	N/A	-18,047 Closed	0 $0
Q1 2021 May 13, 2021	SELL	N/A	-3,086 Reduced 14.6%	18,047 $3.91 Million
Q4 2020 Feb 09, 2021	SELL	N/A	-2,841 Reduced 11.85%	21,133 $2.44 Million
Q3 2020 Nov 12, 2020	SELL	N/A	-8,146 Reduced 25.36%	23,974 $2.33 Million
Q2 2020 Aug 10, 2020	BUY	N/A	2,900 Added 9.92%	32,120 $3.94 Million
Q1 2020 May 12, 2020	BUY	N/A	7,117 Added 32.2%	29,220 $2.56 Million
Q4 2019 Feb 13, 2020	BUY	N/A	4,065 Added 22.54%	22,103 $2.31 Million
Q3 2019 Nov 08, 2019	SELL	N/A	-13,512 Reduced 42.83%	18,038 $2.08 Million
Q2 2019 Aug 07, 2019	BUY	N/A	1,602 Added 5.35%	31,550 $5.44 Million
Q1 2019 May 13, 2019	SELL	N/A	-17,447 Reduced 36.81%	29,948 $5.05 Million
Q4 2018 Feb 12, 2019	BUY	N/A	8,568 Added 22.07%	47,395 $4.62 Million
Q3 2018 Nov 13, 2018	SELL	N/A	-8,319 Reduced 17.65%	38,827 $6.71 Million
Q2 2018 Aug 13, 2018	BUY	N/A	5,094 Added 12.11%	47,146 $6.58 Million
Q1 2018 May 11, 2018	BUY	N/A	4,969 Added 13.4%	42,052 $4.74 Million
Q4 2017 Feb 12, 2018	SELL	N/A	-260 Reduced 0.7%	37,083 $4.9 Million
Q3 2017 Nov 09, 2017	BUY	N/A	16,003 Added 74.99%	37,343 $3.79 Million
Q2 2017 Aug 11, 2017	BUY	N/A	21,340	21,340 $2.14 Million

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.